Relapsing-remitting multiple sclerosis and Allergy to arthropod sting

Summary:

Allergy to arthropod sting is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Allergy to arthropod sting with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 18 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Allergy to arthropod sting?

Allergy to arthropod sting is found to be associated with 83 drugs and 173 conditions by eHealthMe. Check the latest studies of Allergy to arthropod sting.



On Jul, 18, 2026

18 people who have Relapsing-Remitting Multiple Sclerosis and Allergy To Arthropod Sting are studied.

Would you have Allergy to arthropod sting when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Allergy To Arthropod Sting *:

  • female: 58.82 %
  • male: 41.18 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Allergy To Arthropod Sting *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 21.43 %
  • 40-49: 71.43 %
  • 50-59: 0.0 %
  • 60+: 7.14 %

Common drugs taken by these people *:

  1. Ocrevus: 11 people, 61.11%
  2. Lyrica: 9 people, 50.00%
  3. Jardiance: 6 people, 33.33%
  4. Trulicity: 6 people, 33.33%
  5. Vitamin D3: 6 people, 33.33%
  6. Lantus: 6 people, 33.33%
  7. Aspirin: 5 people, 27.78%
  8. Levothyroxine Sodium: 5 people, 27.78%
  9. Acyclovir: 5 people, 27.78%
  10. Sitagliptin Phosphate: 5 people, 27.78%

Common symptoms for these people *:

  1. Blepharitis (chronic inflammation of the eyelid): 9 people, 50.00%
  2. Urticaria (rash of round, red welts on the skin that itch intensely): 9 people, 50.00%
  3. Fatigue (feeling of tiredness): 9 people, 50.00%
  4. Hypotonia (low muscle tone): 6 people, 33.33%
  5. Oral Candidiasis (fungal infection of mouth): 6 people, 33.33%
  6. Blood Glucose Increased: 6 people, 33.33%
  7. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 6 people, 33.33%
  8. Meningitis Viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 6 people, 33.33%
  9. Itching: 6 people, 33.33%
  10. Injection Site Nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site): 6 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Allergy to arthropod sting?

- Check whether Allergy to arthropod sting is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Allergy to arthropod sting:

All the conditions that are associated with Allergy to arthropod sting:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Allergy to arthropod sting and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: